X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
5Y CAGR+38.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+38.4%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
5.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$6.26M+685.1%
2024$797000.00-
2023$0.00-
2022$0.00-100.0%
2021$1.89M+53.8%
2020$1.23M+83.0%
2019$672000.00+552.4%
2018$103000.00-47.2%
2017$195000.00-35.0%
2016$300000.00-